News Kissei Pharmaceutical Co., Ltd.

Equities

4547

JP3240600001

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
3,585 ^JPY	+1.41%		+4.82%	+16.02%

Mar. 20	Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program	MT
Mar. 19	Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Final dividend	Mar. 27	FA
Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program	Mar. 20	MT
Kissei Pharmaceutical : Notice Concerning Status of Acquisition and Completion of the Company's Own Shares	Mar. 19	PU
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	Mar. 19	CI
Kissei Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 8, 2023, has closed with 1,909,900 shares, representing 4.18% for ¥5,999.99 million.	Mar. 17	CI
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	Mar. 01	PU
Kissei Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 2024	Jan. 30	CI
Kissei Pharmaceutical Repurchases 251 Million Yen Worth of Shares in December 2023	Jan. 04	MT
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	Jan. 04	CI
Kissei and Maruishi Debut Injection for Dialysis-Related Itching	Dec. 12	MT
Kissei Pharmaceutical : KORSUVA® IV Injection Syringe for Dialysis 17.5μg, 25.0μg and 35.0μg to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	Dec. 12	PU
Kissei Pharmaceutical Co., Ltd. and Maruishi Pharmaceutical Co., Ltd. Announces KORSUVA®? IV Injection Syringe for Dialysis 17.5ug, 25.0ug to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	Dec. 12	CI
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	Dec. 01	PU
Kissei Pharmaceutical : Introduces Natural Language Processing System	Nov. 17	PU
Japanese Shares Close Lower on Tuesday After Key Economic Data	Nov. 07	MT
Kissei Pharmaceutical's Fiscal H1 Attributable Profit Surges as Net Sales Gains	Nov. 07	MT
Kissei Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 06	CI
Kissei Pharmaceutical Co., Ltd. Announces Second Quarter-End Dividend for the Year Ending March 31, 2024, Payable on December 4, 2023 and Provided Dividend Guidance for the Year Ending March 31, 2024	Nov. 06	CI
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	Oct. 31	PU
Jefferies Downgrades Kissei Pharmaceutical to Hold From Buy, Adjusts Price Target to 3,400 Yen From 3,300 Yen	23-10-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kissei Pharmaceutical Co., Ltd.

Equities

4547

JP3240600001

Summary

Filters